Betel

Betel (Piper betle L.): A Comprehensive Reference

1. Identity and Botanical Description

Taxonomic Classification and Nomenclature

Piper betle L. (synonym: Piper betel Blanco), commonly called betel vine or betelvine, is an economically and medicinally important cash crop belonging to the family Piperaceae, often referred to as "green gold." The genus name Piper places it squarely within the pepper family, closely related to black pepper (Piper nigrum) and long pepper (Piper longum). The leaf is the primary part used medicinally and culturally; the plant is also known in Sanskrit as Tambul and in Indian vernacular as paan.

Morphology and Cultivation

Betel leaf belongs to the Piperaceae family and is an aromatic perennial vine with a heart-shaped appearance. It is a perennial dioecious creeper, probably native to Malaysia but cultivated in India for its leaves, used for chewing. The plant is highly sought after in India, Malaysia, Thailand, Sri Lanka, Taiwan, and other Southeast Asian countries because of its positive effects on oral health.

A wide diversity of bioactive compounds is present in the leaves of betel, and this difference is based on the environment, soil types, the location of growing, and types of landraces. The plant is cultivated in dozens of named cultivars or "landraces" across South and Southeast Asia, each with distinct phytochemical profiles. Examples documented in research include the Bangla, Magahi, Sagar Bangla, and Kapoori cultivars, which differ substantially in essential oil composition.

Common Forms and Preparations

The betel leaf and products produced in different forms such as powder, capsules, liquid, and various types of value-added products are available on a broad spectrum in the market as beverages, in oral care, pharmaceutical products, and cosmetics. In traditional and contemporary use, the leaf is employed fresh, dried, as aqueous or alcoholic extracts, as an essential oil, and incorporated into toothpastes, mouthrinses, and topical preparations. Researchers have used hot water extracts (HWE), cold ethanolic extracts (CEE), methanolic extracts, and supercritical CO₂ extracts in experimental investigations. Since the traditional use of P. betle involves chewing, it offers possibilities of use in drug delivery through buccal mucosa, bypassing the gastric route.

The classic chewed preparation is the betel quid, which wraps various combinations of areca nut (Areca catechu), slaked lime (calcium hydroxide), and sometimes tobacco in a betel leaf. The way betel leaf is chewed varies from one country to another; in some regions it is chewed with areca nut and slaked lime, in others it is mixed with tobacco, spices, or other ingredients for added flavour. The safety implications of these added constituents—especially areca nut and tobacco—are critically distinct from those of the leaf alone (see Safety section).

---

2. Traditional and Historical Use

Archaeological and Written Records

In India, betel leaf plays an important role since ancient culture. Its use in India dates back to 400 BC. As per ancient books of Ayurveda—Charaka, Sushruta Samhitas, and Kashyapa Bhojanakalpa—the practice of chewing betel leaf after meals became common between 75 AD and 300 AD.

Betel vine and areca nut palm are not indigenous to India. Historical, epigraphic, philological, and archaeological evidence reveals their original home to be the Indonesian archipelago. This complementary pair entered India during the early Gupta period and merged into Indian culture, with their popularity increasing steadily until they became a commodity of common use.

There is archaeological evidence that the betel leaves have been chewed along with the areca nut since very ancient times.

Cultural and Ceremonial Roles

Their uses vary from masticatory to medicinal, and the duo's presence is noticed in all social and religious ceremonies and as an offering to gods. Betel leaf and areca nut are regarded as auspicious symbols of hospitality and denote a moral, social, and legal commitment. Malay culture and tradition hold betel nut and betel leaves in high esteem, evident through their use in many social and religious ceremonies. In an Assamese marriage, they are conspicuously present in around 15 ceremonies.

In Vietnam, betel leaf and areca nut are prominent features in traditional wedding ceremonies and many other formal situations. In Papua New Guinea, where the preparation is known as buai, betel use is prolific and occurs on every street corner. In Thailand, betel leaves are included in traditional wedding ceremonies as a symbol of love and fidelity. During cultural events and religious festivals in Indonesia, hosts often offer it to guests as a mark of respect and hospitality.

Traditional Medicinal Uses by System and Culture

The plant is cultivated primarily in South East Asian countries for its beautiful glossy heart-shaped leaves, which are chewed or consumed as betel quid and widely used in Chinese and Indian folk medicine as carminative, stimulant, astringent, against parasitic worms, conjunctivitis, rheumatism, wound treatment, etc., and is also used for religious purposes.

In Chinese folk medicine, betel leaves are used for the treatment of various disorders and are claimed to have detoxification, antioxidation, and antimutation properties. In folk medicine, betel quid chewing has been used as a remedy for bad breath, intestinal parasites, headaches, and infections of the skin.

The leaf is traditionally described as carminative, aphrodisiac, tonic, laxative, and as improving appetite. In various traditions, P. betle leaves are used in traditional medicine to cure skin conditions, treat oral and dental problems, headaches, arthritis, and joint discomfort, as well as as a mouthwash to curb bad breath.

The leaves are also used for medicinal purposes, including to treat gastrointestinal disorders, ease flatulence, and improve digestion. Betel leaf extracts were a popular ingredient in food preparation in ancient times; the leaves were used to add flavor and aroma to dishes, as well as to act as a preservative.

---

3. Phytochemistry: Key Constituents and Active Compounds

Essential Oil and Phenylpropanoids

Betel leaves contain 0.15% to 0.2% essential oil, which is classified as monoterpenes, sesquiterpenes, phenylpropanoids, and aldehydes. The constituents of betel leaf essential oil (BLEO) are strongly dependent on botanical origin, age of the plant, and harvesting time. GC-MS analysis of BLEO from different places in India showed that phenylpropanoid groups such as acetyl eugenol, eugenol, chavicol, and safrole were the major components. Interestingly, Indian BLEO obtained from the Sagar Bangla cultivar contained chavicol, but not from the Magahi cultivar.

One study revealed that BLEO contained eugenol (40%) and a combination of carvacrol and chavicol (up to 40%) with chavibetol as a marker compound. Another study found additional main compounds including estragole, linalool, α-copaene, anethole, caryophyllene, α-terpinene, p-cymene, 1,8-cineole, β-caryophyllene, α-humulene, allyl pyrocatechol, allylcatechol, methyl eugenol, estragol (methyl chavicol), chavibetol, chavibetol acetate, safrole, 4-allyl-2-methoxy-phenolacetate, and 3-allyl-6-methoxyphenol.

Phenolic Compounds

Betel leaves contain phenolic compounds such as eugenol, chavibetol, allylpyrocatechol, and hydroxychavicol. The flavonoids in betel leaves include quercetin, kaempferol, and catechin. Widely consumed in South Asian countries, the glossy leaf contains a multitude of biophenolics such as hydroxychavicol, eugenol, chavibetol, and piperols.

Hydroxychavicol is the most important bioactive compound among the wide range of phytoconstituents found in the essential oil and extracts. The active compounds isolated from the leaf and other parts are hydroxychavicol, hydroxychavicol acetate, allylpyrocatechol, chavibetol, piperbetol, methylpiperbetol, piperol A, and piperol B.

Monoterpenes and Sesquiterpenes

GC-MS studies identified all compounds that can be divided as monoterpenes (α-thujene, α-pinene, camphene, sabinene, myrcene, β-phellandrene, α-terpinene, (E)-β-ocimene, 1,8-cineole/eucalyptol, γ-terpinene, terpinolene, linalool, terpinen-4-ol, α-terpineol), sesquiterpenes (δ-elemene, α-copaene, β-copaene, β-elemene, E-β-caryophyllene, γ-elemene, β-selinene, aromadendrene, α-humulene, germacrene D, α-selinene, γ-muurolene, bicyclogermacrene, α-muurolene, cis-β-guaiene, δ-cadinene, palustrol, spathulenol, caryophyllene oxide, globulol, viridiflorol, cubenol, α-cadinol), and phenylpropanes (estragole/methyl chavicol, chavicol, anethole/isoestragole, safrole, chavicol acetate, eugenol, methyl eugenol, eugenol acetate).

Stem and Root Constituents

The betel stems were found to contain stigmast-4-en-3, piperine, piperlonguminine, piperdardine, dehydropipernonaline, guineensine, aristololactam A-II, pellitorine, 4-allyl resorcinol, syringaresinol-O-β-D-glucopyranoside, N-isobutyl-2E,4E-dodecadienamide, pinoresinol, piperolein-B, cepharadione A, dotriacontanoic acid, β-daucosterol, tritriacontane, and β-sitosterol, among others. Column chromatography of the alcoholic extract of Piper betle roots furnished aristololactam A-II and a new phenyl propene characterized as 4-allyl resorcinol, while the petroleum-ether extract yielded a diketosteroid, stigmast-4-en-3,6-dione.

Mechanisms of Action of Key Constituents

Hydroxychavicol (HC): Hydroxychavicol (HC), a primary constituent of P. betle leaves, is known to possess antiproliferative activity at micromolar doses on various cancer cell lines of different origins while leaving normal cells unharmed. HC has been shown to have anti-mutagenic and anti-carcinogenic activity and possesses antimicrobial, antioxidant, and anti-inflammatory properties.

Anti-inflammatory signaling: The leaf constituents modulate an extensive array of signaling molecules such as transcription factors as well as reactive oxygen species (ROS) to control multiple nodes of various cellular proliferation and death pathways.

Antiplatelet activity of hydroxychavicol: Hydroxychavicol inhibited arachidonic acid (AA) and collagen-induced platelet aggregation and thromboxane B2 (TXB2) production. HC inhibited thrombin-induced TXB2 production, but not platelet aggregation. HC also suppressed COX-1/COX-2 enzyme activity and AA-induced ROS production and Ca²⁺ mobilization.

Apoptosis induction: Studies aimed at elucidating the antiproliferative mechanism of hydroxychavicol investigated its effects on cell cycle, apoptosis, and the expression of c-Jun N-terminal kinase (JNK) and P38 mitogen-activated protein kinase (MAPK) in HT-29 colon cancer cells.

Antioxidant mechanisms: Heart-shaped Piper betle leaves are magnificent reservoirs of phenolic compounds with antiproliferative, antimutagenic, antibacterial, and antioxidant properties. The antioxidant activity is attributed particularly to phenolics such as eugenol, hydroxychavicol, and catechol, which scavenge free radicals and modulate superoxide dismutase (SOD) and catalase (CAT) activity.

---

4. Scientific Evidence by Area of Use

4.1 Oral Health: Antimicrobial, Antiplaque, and Antihalitosis Effects

Scientific studies have shown that the betel leaf effectively inhibits the growth of oral pathogens, reducing halitosis, dental plaque, and incidences of gingival diseases.

Clinical human evidence:

A randomized clinical crossover study published in 2022 evaluated betel leaf toothpaste in human subjects. This randomized clinical crossover pilot study enrolled 60 individuals with mild gingivitis; they were segregated into two groups by drawing lots, and the study lasted 20 days with a two-week washout period between miswak and betel leaf toothpaste. The results revealed that betel leaf and miswak herbal toothpaste significantly decreased plaque index. Nevertheless, betel leaf toothpaste caused a more significant reduction in gingival bleeding scores (p < 0.001) compared to miswak (p = 0.007). No significant decrease in gingival and plaque index was seen when subjects returned to their conventional chemical toothpaste.

A study on chewing betel leaves showed that the saliva obtained after mastication of an entire leaf reduced the microflora by approximately 56%. This constitutes direct (though limited) human-relevant data on oral antimicrobial effects.

In vitro evidence:

One study determined the antimicrobial activities of ethanol, methanol, and supercritical CO₂ extracts of Philippine Piper betle on clinical isolates of multiple drug-resistant bacteria. Assay methods included the standard disc diffusion method and the broth microdilution method for the determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC). The study revealed bactericidal activities of all P. betle leaf crude extracts on methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended spectrum β-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and metallo-β-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii, with minimum bactericidal concentrations ranging from 19 μg/ml to 1250 μg/ml. The extracts proved more potent against Gram-positive MRSA and VRE than against Gram-negative bacteria; VRE isolates were more susceptible to all extracts than MRSA isolates. Generally, ethanol extracts proved more potent than methanol or supercritical CO₂ extracts.

Evidence assessment: The oral health evidence is supported by at least one small randomized controlled trial and numerous in vitro studies, but the clinical trial base is small (n=60, pilot, single center). Evidence is promising but not yet conclusive for recommending specific clinical applications.

4.2 Antidiabetic / Blood Glucose Modulation

Animal studies:

Leaves of Piper betle possess several bioactivities and are used in traditional medicinal systems. Its antidiabetic activity had not been scientifically investigated until a study aimed to investigate antidiabetic activity of Piper betle leaves, tested in normoglycaemic and streptozotocin (STZ)-induced diabetic rats using oral administration of hot water extract (HWE) and cold ethanolic extract (CEE). In normoglycaemic rats, both HWE and CEE significantly lowered the blood glucose level in a dose-dependent manner. In the glucose tolerance test, both extracts markedly reduced the external glucose load. The antidiabetic activity of HWE was comparable to that of CEE. However, HWE failed to inhibit glucose absorption from the small intestine. Both extracts were found to be non-toxic and well tolerated after chronic oral administration, with no overt signs of toxicity, hepatotoxicity, or renotoxicity.

Evidence assessment: Current evidence for antidiabetic activity is limited to animal models. No published human clinical trials specifically establishing glucose-lowering efficacy in diabetic patients were identified in this review. Results from animal studies cannot be directly extrapolated to humans.

4.3 Anti-inflammatory and Immunomodulatory Effects

Several investigations have revealed drug-related properties of P. betle including antioxidant, anti-inflammatory, antimalarial, antidiabetic, and gastro- and hepatoprotective activities.

Anti-inflammatory mechanisms have been studied predominantly in cellular and animal models. Ethanolic extract has been shown to mediate anti-inflammatory activity via down-regulation of nitric oxide in ex vivo models. An ethanol extract of Piper betle Linn. mediates its anti-inflammatory activity via down-regulation of nitric oxide. A study on burn-induced wounds in rats treated with betel leaf extract, which contains similar flavonoids, reported enhanced fibroblast activity, further supporting the regenerative potential of these compounds.

Evidence assessment: Anti-inflammatory evidence is primarily preclinical (in vitro, animal). No rigorous controlled human clinical trials specifically measuring anti-inflammatory endpoints for P. betle leaf preparations were identified.

4.4 Antiplatelet and Cardiovascular Effects

Platelet hyperactivity is important in the pathogenesis of cardiovascular diseases. Betel leaf (PBL) is consumed by an estimated 200–600 million betel quid chewers worldwide. Hydroxychavicol (HC), a betel leaf component, was tested for its antiplatelet effect. Researchers tested the effect of HC on platelet aggregation, thromboxane B2 (TXB2) and reactive oxygen species (ROS) production, cyclooxygenase (COX) activity, ex vivo platelet aggregation, and mouse bleeding time and platelet plug formation in vivo; pharmacokinetics of HC in rats was also assessed.

Evidence assessment: Antiplatelet evidence is based on ex vivo laboratory assays and animal models. The implications of COX-1/COX-2 inhibition by hydroxychavicol in humans have not been tested in controlled clinical trials and warrant caution when combined with antiplatelet or anticoagulant medications.

4.5 Gastroprotection and Antiulcer Effects

Oral administration of ethanol leaf extract at 200 mg/kg body weight for ten days showed noteworthy protection against gastric lesions, increased SOD and CAT activity, amplification of mucus quantity, increase in hexosamine and total thiol group quantity, while reducing the amount of damaged oxidative protein and peroxidized lipid level, thus proving the antiulcerogenic potential of betel by an antioxidant mechanism. In another experiment, the ethanolic extract of betel leaves was found to protect against NSAID-induced ulcer in Charles Foster rats by increasing antioxidative factors, mucus, and the total gastric tissue sulfhydryl group. The ethanol extract of betel leaves and the isolated compound allylpyrocatechol were found to have excellent healing properties against indomethacin-induced stomach ulceration in rats.

Evidence assessment: Gastroprotection and antiulcer data are entirely from animal (rodent) models. No human clinical trials have been conducted. The evidence is preliminary and cannot be generalized to human patients.

4.6 Anticancer and Chemopreventive Activity

Data underscore the remarkable chemotherapeutic and chemopreventive potential of betel leaves. Heart-shaped Piper betle leaves are reservoirs of phenolic compounds with antiproliferative, antimutagenic, antibacterial, and antioxidant properties.

Hydroxychavicol (HC), a primary constituent of P. betle leaves, is known to possess antiproliferative activity at micromolar doses on various cancer cell lines of different origins while leaving normal cells unharmed. In a study of HC in HT-29 colon cancer cells, its effects on cell cycle, apoptosis, and the expression of c-Jun N-terminal kinase (JNK) and P38 mitogen-activated protein kinase (MAPK) in HT-29 colon cancer cells were investigated.

In an animal model of antitumor activity, at 24 hours post-intraperitoneal inoculation of tumor cells into mice, extracts were administered at 25, 50, and 100 mg/kg body weight for nine consecutive days; antitumor effects were assessed according to tumor volume, packed cell count, viable and non-viable tumor cell count, median survival time, and increase in life span of Ehrlich ascites carcinoma (EAC)-bearing mice. MPBL and ethylacetate fraction (EPBL) at a dose of 100 mg/kg induced significant decrease in tumor volume, packed cell volume, and viable cell count and increased the life span of EAC-bearing mice. Hematological and serum biochemical profiles were restored to normal levels in extract-treated mice.

Evidence assessment: Anticancer evidence is based exclusively on in vitro (cell line) and animal (rodent) models. No human clinical trials on anticancer activity of P. betle leaf preparations have been published. These findings, while mechanistically interesting, are preliminary and cannot be interpreted as evidence of efficacy in human cancer patients.

4.7 Cellular Aging and Fibroblast Modulation

The effect of P. betle aqueous extracts on replicative senescent human diploid fibroblasts (HDFs) was investigated by determining the expressions of senescence-associated genes using quantitative PCR. Results showed that P. betle extracts at 0.4 mg/ml can improve cell proliferation of young (143%), presenescent (127.3%), and senescent (157.3%) HDFs. Increased expressions of PRDX6, TP53, CDKN2A, PAK2, and MAPK14 were observed in senescent HDFs compared to young and/or presenescent HDFs. Treatment with P. betle extracts modulates the transcriptional profile changes in senescent HDFs.

Evidence assessment: This research is at the in vitro/cellular level. While it provides mechanistic insight into potential anti-aging molecular effects, no human clinical evidence has been established.

---

5. Body Systems and Health Areas Associated with Betel

• Oral/Dental System: The leaf extract, fractions, and purified compounds are found to play a role in oral hygiene, and to have various properties including anti-diabetic, cardiovascular, anti-inflammatory/immunomodulatory, anti-ulcer, hepato-protective, anti-infective, etc. Specific oral applications include antiplaque, antihalitosis, antifungal (e.g., against oral Candida), and gingival health.
• Gastrointestinal System: Carminative, digestive aid, antiulcer, and gastroprotective uses are documented in traditional medicine and animal studies.
• Cardiovascular System: Antiplatelet and thromboxane-inhibitory effects of hydroxychavicol identified in laboratory and animal studies.
• Metabolic/Endocrine: Antidiabetic (blood glucose-lowering) activity in animal models.
• Integumentary System: Wound healing, skin infection treatment, and anti-inflammatory topical applications in traditional use and animal studies.
• Oncology (preclinical): Antiproliferative and chemopreventive activity in cell culture and rodent models across multiple cancer types.
• Immune System: Immunomodulatory effects and down-regulation of inflammatory mediators (nitric oxide, cytokines) described in preclinical models.
• Respiratory System: Piper betle can be used for treating alcoholism, asthma, and bronchitis according to traditional records, though clinical evidence is lacking.

---

6. Dosage Forms and Reported Study Dosages

The following dosages reflect those actually reported in peer-reviewed experimental studies and should not be interpreted as recommended doses for human use:

• Antidiabetic (animal, oral): Hot water extract (HWE) and cold ethanolic extract (CEE) were administered orally to normoglycaemic and STZ-induced diabetic rats. Dose-dependent blood glucose lowering was observed, though specific dose figures were not provided in the abstract data available.
• Antiulcer (animal, oral): Oral administration of ethanol leaf extract at 200 mg/kg body weight for ten days was the dose used in one rat study showing gastroprotection.
• Antitumor (animal, intraperitoneal): Extracts were administered at 25, 50, and 100 mg/kg body weight for nine consecutive days in a murine Ehrlich ascites carcinoma model.
• Cellular aging (in vitro): P. betle extracts at 0.4 mg/ml were used in the study of senescent human diploid fibroblast proliferation.
• Oral health (human clinical, toothpaste form): The study lasted 20 days and included a two-week washout period between miswak and betel leaf toothpaste use in 60 participants. Specific concentration of active leaf extract in the toothpaste formulation was not reported in the abstract data.
• Antibacterial (in vitro): Minimum bactericidal concentrations ranged from 19 μg/ml to 1250 μg/ml against multiple drug-resistant bacterial strains in laboratory assays.
• Toxicity threshold (animal, oral acute): An acute toxicity study in both male and female ICR mice showed the safety of the methanol extract of betel leaves orally, with the median lethal dose (LD50) higher than 5000 mg/kg body weight.

---

7. Safety Considerations and Interactions

7.1 The Critical Distinction: Betel Leaf Alone vs. Betel Quid

The most important safety issue in the betel literature is the sharp distinction between the betel leaf itself and the complex preparations containing areca nut, lime, and/or tobacco that are chewed as betel quid. Compared to the leaf alone, the quid made up of areca nut (Areca catechu), tobacco (Nicotiana tabacum), and slaked lime is a highly abused recreational agent and is documented to be a causative agent for oral cancer. Although beneficial, the betel leaf is highly maligned for the wrong reasons, and its consumption as a dietary agent is not appreciated in many societies.

Various experiments evaluating effects of betel leaf suggested no harmful effect when consumed alone.

7.2 IARC Classification of Betel Quid

In 2004, the International Agency for Research on Cancer (IARC) revised its conclusion that betel quid, both with and without tobacco, as well as areca nut alone, was carcinogenic to humans.

The IARC experts determined that betel quid with tobacco causes oral cancer, cancer of the pharynx, and cancer of the oesophagus in humans. Areca nut, a common component of all betel quid preparations, has been observed to cause oral submucous fibrosis, a pre-cancerous condition that can progress to malignant oral cancer, leading to the determination that areca nut itself is carcinogenic to humans. Studies among Asian migrant communities have demonstrated a significantly higher risk for oral cancer compared with natives of countries where they have settled. Oral cancers are more common in parts of the world where betel quid is chewed; of the 390,000 oral and oro-pharyngeal cancers estimated annually worldwide, 228,000 (58%) occur in South and Southeast Asia.

Areca nut chewing is one of the major risk factors for oral cancer, with large-magnitude risks reported in studies comparing betel quid chewers and never users, and it has been evaluated as a Group 1 carcinogen by the International Agency for Research on Cancer. Data from a high-quality meta-analysis examining risk estimates showed a pooled adjusted relative risk of 7.9 (95% CI, 7.1 to 8.7). The risk of oral cancer increases in a dose-response manner with the daily number of quids consumed and the number of years chewing.

Betel-quid or areca-nut chewing results in exposure to areca nut alkaloids, N-nitroso-compounds formed from these compounds during chewing, polyphenols, trace elements, and in some cases, tobacco.

7.3 Role of Individual Components in Carcinogenesis

The carcinogenic risk of betel quid has been carefully apportioned to its components. Although it might seem reasonable to suspect safrole in Piper betle as the cause of genotoxicity of betel quid, Piper betle is in fact antimutagenic, antigenotoxic, and anticarcinogenic in human and animal models. The reason why many betel quid chewers develop cancers must therefore be due to one or more other carcinogens. Areca nut contains the alkaloids arecoline and arecaidine, both of which are genotoxic. Arecoline also depletes antioxidant enzymes and is cytotoxic to human oral mucosal cells. Areca nut extract was genotoxic to human gingival keratinocytes, and areca-derived carcinogenic nitrosamines have been found in the saliva of betel chewers.

7.4 Safrole and Estragole Content

Betel quid chewing has been associated with an increased risk of oral squamous cell carcinoma (OSCC) and oral submucous fibrosis (OSF). Piper betle inflorescence, which contains 15 mg/g safrole, is a unique ingredient of betel quid in Taiwan. Chewing such prepared betel quid may contribute to safrole exposure in human beings (420 μM safrole in saliva). Safrole is a known rodent hepatocarcinogen, yet its carcinogenicity in human beings is largely undetermined. Notably, the inflorescence (flower spike) — not the leaf — is the principal source of safrole in Taiwanese preparations.

Risk assessment of the consumption of plant food supplements containing safrole based on the margin of exposure concludes that the use of supplements containing safrole might raise a potential concern for human health. However, this analysis is based on studies administering high doses of pure safrole to rodents rather than dosing a form of multicomponent extract or the botanical as such, because results obtained with the herb or its extract containing the genotoxic compound in its food matrix are different from those obtained with the purified carcinogenic compound. Such differences may arise when additional compounds in the food matrix interfere with the carcinogenic activation of the genotoxic compound.

7.5 Preclinical Toxicology of the Leaf Itself

There was also an evaluation of oral acute and sub-acute toxicity (28 days) and genotoxicity of a herbal formulation containing betel leaves alcoholic extract in rats and cellular models. This study revealed the absence of major adverse reactions. Moreover, betel leaves were considered safe in terms of hematotoxicity, hepatotoxicity, genotoxicity, weights of organs, gross morphology, stress, or aversive behaviors in rats.

Both hot water and cold ethanolic extracts were found to be non-toxic and well tolerated after chronic oral administration, with no overt signs of toxicity, hepatotoxicity, or renotoxicity in the rat antidiabetic study.

7.6 Potential Drug Interactions

The inhibition of COX-1 and COX-2 enzymes by hydroxychavicol and suppression of platelet aggregation, as demonstrated in ex vivo and animal studies, raises a theoretical concern about additive bleeding risk in individuals taking antiplatelet drugs (e.g., aspirin, clopidogrel) or anticoagulants. This has not been studied in controlled human trials. Similarly, the demonstrated blood glucose-lowering effect in diabetic animal models implies a potential for additive hypoglycemic effects if used alongside antidiabetic medications, though human data are absent.

7.7 Liver Effects with Betel Quid (Quid, Not Leaf Alone)

Research aids in the identification of a link between the occurrence of oral submucous fibrosis, oral squamous cell carcinoma, liver damage, and the practice of eating betel nuts. Chewing betel quid on a regular basis appears to be a separate risk factor for liver damage, oral squamous cell carcinoma, and oral submucous fibrosis. This risk pertains to the full quid preparation rather than to betel leaf in isolation.

7.8 Distinction from Areca Nut / "Betel Nut"

A critical terminological note: the term "betel nut" refers to the seed of Areca catechu, which is an entirely different plant. Areca nut is the component of betel quid responsible for the strongest carcinogenic and psychoactive effects (via the alkaloid arecoline). Piper betle leaf — the subject of this article — is the vine leaf used to wrap areca nut preparations, and its individual safety profile is substantially more favorable than that of the full quid, though it too contains potentially bioactive phenylpropanoids (safrole, estragole, eugenol) whose long-term safety at high doses in humans has not been established in controlled prospective studies.

---

References

• Biswas P et al. (2022). Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes. Journal of Cell and Molecular Medicine. PMC9170825.
• Pradhan D et al. (2013). Betel leaf: Revisiting the benefits of an ancient Indian herb. Asian Pacific Journal of Tropical Biomedicine. PMC3892533.
• Wiweko S et al. (2021). Piper betle (L): Recent Review of Antibacterial and Antifungal Properties, Safety Profiles, and Commercial Applications. Molecules, 26(8):2321. PMC8073370.
• Sarkar M et al. (2007). Chemical Constituents of Piper betle Linn. (Piperaceae) roots. Asian Pacific Journal of Tropical Biomedicine. PMC6147577.
• Mohamad NA et al. (2022). Hydroxychavicol as a potential anticancer agent (Review). Oncology Letters, 25(1):34. PMC9773318.
• Ng KW et al. (2021). Hydroxychavicol, a polyphenol from Piper betle leaf extract, induces cell cycle arrest and apoptosis in TP53-resistant HT-29 colon cancer cells. Journal of Zhejiang University Science B. PMC7897596.
• Deb S et al. (2007). Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization. British Journal of Pharmacology. PMC1978281.
• Varma SR et al. (2022). Effect of a Novel Betel Leaf Dentifrice on Commonly Seen Oral Hygiene Parameters — A Randomized Clinical Crossover Study. International Journal of Environmental Research and Public Health. PMC9498039.
• Ghosh J et al. (2015). Piper betle extracts exhibit antitumor activity by augmenting antioxidant potential. Oncology Letters. PMC4301554.
• Kang YC et al. (2017). Piper betle L. Modulates Senescence-Associated Genes Expression in Replicative Senescent Human Diploid Fibroblasts. Oxidative Medicine and Cellular Longevity. PMC5449738.
• Charirak W et al. (2023). In Vitro Antibacterial Activity and Mode of Action of Piper betle Extracts against Soft Rot Disease-Causing Bacteria. Scientifica. PMC10522424.
• Kloucek P et al. (2015). Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance. PMC4704777.
• Arambewela LSR et al. (2005). Antidiabetic activities of aqueous and ethanolic extracts of Piper betle leaves in rats. Journal of Ethnopharmacology, 102(2):239–245. PubMed 16055288.
• WHO / IARC (2003). IARC Monographs Programme finds betel-quid and areca-nut chewing carcinogenic to humans. World Health Organization.
• Warnakulasuriya S et al. (2022). Areca Nut and Oral Cancer: Evidence from Studies Conducted in Humans. PMC9397398.
• IARC (1987). Overall Evaluations of Carcinogenicity: Betel Quid with Tobacco (Group 1) and Betel Quid without Tobacco (Group 3). NCBI Bookshelf NBK533586.
• IARC Monographs Volume 85: Betel-quid and Areca-nut Chewing and Some Areca-nut-derived Nitrosamines. International Agency for Research on Cancer.
• Kumar A et al. (2024). Ultrasound assisted extraction of phytochemicals from Piper betel L. PMC11107348.
• Prabhu RV et al. (2011). Betel leaf and betel nut in India: History and uses. ResearchGate.
• ScienceDirect (2023). A literature review on bioactive properties of betel leaf (Piper betel L.) and its applications in food industry.
• ScienceDirect Topics. Safrole — Overview (includes discussion of betel quid, genotoxicity of betel leaf vs. areca nut components).
• Herbal remedies for oral and dental health: a comprehensive review. PMC11914039.